Daniel Temeles, MD
Hematology & Oncology · Roanoke, VANPI 1699741629
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $188 of the $247 with a category attached, or 76.1%. 5 manufacturers reported payments, led by Tactile Systems Technology Inc at 45.5% of the total. Reporting peaked in 2022 at $112 and has fallen 72.7% since, to $31 in 2025. That places this record below the midpoint for hematology & oncology clinicians in VA, where the typical reported total is $1,232.
Across 6 payments — averaging $41.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$112
- Karyopharm Therapeutics Inc.$76
- Pfizer$31
- CSL Behring$16
- Gilead$12
What the payments were for
- Food & beverage$18876%
- Education$5924%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 2 | $112 |
| Karyopharm Therapeutics Inc. | 1 | $76 |
| Pfizer | 1 | $31 |
| CSL Behring | 1 | $16 |
| Gilead | 1 | $12 |
How this compares
$247 in reported general payments places this provider in the 20th percentile of 293 hematology & oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $18,610 |
| Oxycodone Hcl | 40 | $1,138 |
| Hydroxyurea | 49 | $1,066 |
| Anagrelide Hcl | 11 | $888 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $671 |
| Anastrozole | 44 | $615 |
| Gabapentin | 21 | $368 |
| Megestrol Acetate | 14 | $277 |
| Prednisone | 51 | $270 |
| Duloxetine Hcl | 23 | $202 |
| Tamsulosin Hcl | 33 | $175 |
| Warfarin Sodium | 21 | $104 |
| Tramadol Hcl | 21 | $85 |
| Ondansetron Hcl | 22 | $82 |
| Levothyroxine Sodium | 15 | $59 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Roanoke
- Mark KochenderferRoanoke$13K
- Ruby KochharHampton$236K
- Victor YazbeckRichmond$190K
- David ChangNewport News$141K
- William ErshlerFairfax$139K
- Yue ZhangVirginia Beach$105K
- Jerome GoldschmidtChristiansburg$105K
- Attique SamdaniRichmond$104K
- Gary SimmonsNorfolk$82K
- Mark FlemingHampton$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.